NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer

Source: NovaBay Pharmaceuticals

Wednesday, December 06, 2017 | Management/Leadership , NovaBay Pharmaceuticals


NovaBay Pharmaceuticals announced the appointment of Lewis J. Stuart as Chief Commercial Officer. Mr. Stuart joined NovaBay on December 1 and brings more than 30 years of biopharmaceutical industry experience. At NovaBay, he will be responsible for leading all commercial activities, including driving sales and revenue growth of Avenova in new and existing markets, and expanding the company’s global commercial channel.

“Lewis is a results-driven executive with extensive experience in successfully launching and growing major medical products, making him an ideal fit for this position,” Mark Sieczkarek, NovaBay’s President and CEO, said in a company news release. “He joins us with a track record of launching first-in-class products, a focus on maximizing productivity and strategic insights. We look for Lewis to make impactful contributions to our commercial organization as we focus on accelerating sales growth of Avenova, and welcome him to our Company.”

“Avenova offers multiple important benefits to a large and relatively untapped segment of the ophthalmology market,” Mr. Stuart said. “I am delighted to join the NovaBay team and look forward to leading the commercial operations and driving Avenova’s ongoing success.”

Prior to NovaBay, Mr. Stuart was Vice President, U.S. Oncology for Genomic Health, where he led the marketing, sales, and medical affairs teams for their oncology franchise. He was also a member of the Board of Directors for Linkage Biosciences, Inc. recently acquired by Thermo Fisher, Inc.

Previously, he served as President and General Manager of Genetic Technologies, a women’s health/oncology company, where he established a U.S.-based molecular diagnostics division. He has also held leadership positions as Senior Vice President, Commercial Operations at CV Therapeutics, a Gilead Sciences acquisition, and Vice President, Sales & Community Marketing at Agouron Pharmaceuticals, before its acquisition by Pfizer, Inc.

Mr. Stuart holds a BA in Communications & Marketing Management from Virginia Polytechnic and State University.


Comments

You must be logged in to leave a comment.